Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy
Objective: Botulinum toxin (BoNT-A) is widely used in combined treatment for spastic cerebral palsy, but its added value preceding comprehensive rehabilitation for motor impairments, gait, and goal attainment has not been studied. Design: A comparative multi-centre trial, i...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Foundation for Rehabilitation Information
2018-07-01
|
Series: | Journal of Rehabilitation Medicine |
Subjects: | |
Online Access: |
https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2369
|